Bain Capital Public Equity Management II’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-340,926
| Closed | -$13.4M | – | 37 |
|
|
2022
Q2 | $13.4M | Sell |
340,926
-70,929
| -17% | -$2.79M | 0.66% | 25 |
|
|
2022
Q1 | $15.2M | Buy |
411,855
+70,583
| +21% | +$2.6M | 0.49% | 27 |
|
|
2021
Q4 | $15.6M | Sell |
341,272
-310,341
| -48% | -$14.1M | 0.52% | 31 |
|
|
2021
Q3 | $23.3M | Buy |
651,613
+384,347
| +144% | +$13.7M | 0.81% | 26 |
|
|
2021
Q2 | $5.29M | Buy |
267,266
+185,900
| +228% | +$3.68M | 0.23% | 34 |
|
|
2021
Q1 | $1.89M | Buy |
+81,366
| New | +$1.89M | 0.08% | 53 |
|